The present disclosure provides a method for treating and/or preventing coccidiosis, including administering to a subject in need thereof a composition including an effective amount of a Bacillus spp.-fermented product. The Bacillus spp.-fermented product has the potential for development as feed additives and use as a possible solution to treat and/or prevent coccidiosis in the poultry industry.

The present disclosure provides a method for treating and/or preventing coccidiosis, including administering to a subject in need thereof a composition including an effective amount of a Bacillus spp.-fermented product. The Bacillus spp.-fermented product has the potential for development as feed additives and use as a possible solution to treat and/or prevent coccidiosis in the poultry industry.

A method of determining the feed efficiency and methane production of a ruminating animal comprising analyzing the number and/or diversity of a bacterial taxon of a microbiome of the animal or of a gene content of said microbiome, wherein a number and/or diversity of said taxon below a predetermined level is indicative of an animal having a high feed efficiency and low methane production, or a number of genes below a predetermined level is indicative of an animal having a high feed efficiency and low methane production.

The present invention relates to: Podoviridae bacteriophage Vib-PAP-2 (accession number KCTC 12910BP) which has the capability to specifically destroy Vibrio parahaemolyticus, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treating Vibrio parahaemolyticus infections, using a composition containing bacteriophage Vib-PAP-2 as an active ingredient.

The present invention relates to: Podoviridae bacteriophage Vib-PAP-2 (accession number KCTC 12910BP) which has the capability to specifically destroy Vibrio parahaemolyticus, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treating Vibrio parahaemolyticus infections, using a composition containing bacteriophage Vib-PAP-2 as an active ingredient.

The present invention relates to a Myoviridae bacteriophage Vib-PAP-7 (Accession number: KCTC 13247BP) isolated from nature, which has the ability to kill Vibrio parahaemolyticus and has the genome represented by SEQ ID NO: 1, and a method for preventing or treating a disease caused by Vibrio parahaemolyticus using a composition containing the Myoviridae bacteriophage Vib-PAP-7 as an active ingredient.

The present invention relates to a Myoviridae bacteriophage Vib-PAP-7 (Accession number: KCTC 13247BP) isolated from nature, which has the ability to kill Vibrio parahaemolyticus and has the genome represented by SEQ ID NO: 1, and a method for preventing or treating a disease caused by Vibrio parahaemolyticus using a composition containing the Myoviridae bacteriophage Vib-PAP-7 as an active ingredient.

An organic-inorganic hybrid material is disclosed comprising a metal compound and a lignin fraction, as well as processes for preparing the same and uses as an antimicrobial agent in agriculture, and in human and animal food industry.

An organic-inorganic hybrid material is disclosed comprising a metal compound and a lignin fraction, as well as processes for preparing the same and uses as an antimicrobial agent in agriculture, and in human and animal food industry.

The present invention discloses a new method for preventing and controlling bacterial diseases in salmonid fish using Quillaja extracts, wherein said method comprises administering to salmonid fish an effective amount of a medicinal composition comprising a Quillaja saponaria extract as active ingredient.